Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches.
暂无分享,去创建一个
H E Junginger | H. Junginger | G. Borchard | A C van Aelst | I M van der Lubben | J C Verhoef | G Borchard | J. Verhoef | A. V. van Aelst | I. van der Lubben | C. AelstvanA. | M. LubbenvanderI.
[1] A. Jayakrishnan,et al. Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[2] J. Kreuter,et al. Influence of crosslinking on the acid stability and physicochemical properties of chitosan microspheres , 1996 .
[3] C. Ruedl,et al. Oral immunization with poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres containing pneumotropic bacterial antigens. , 1997, International archives of allergy and immunology.
[4] L. Illum,et al. Chitosan and its use as a pharmaceutical excipient. , 1998, Pharmaceutical research.
[5] R. Muzzarelli,et al. Human enzymatic activities related to the therapeutic administration of chitin derivatives , 1997, Cellular and Molecular Life Sciences CMLS.
[6] G. Russell-Jones,et al. Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding , 1988, The Journal of experimental medicine.
[7] R. Mrsny,et al. In Vitro Evaluation of Microparticles and Polymer Gels for Use as Nasal Platforms for Protein Delivery , 1999, Pharmaceutical Research.
[8] H. Greenberg,et al. Protective Immunity Induced by Oral Immunization with a Rotavirus DNA Vaccine Encapsulated in Microparticles , 1998, Journal of Virology.
[9] Krishnendu Roy,et al. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.
[10] R. Rappuoli,et al. Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice. , 1998, Vaccine.
[11] M. Alonso,et al. Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers , 1997 .
[12] Thomas R. Tice,et al. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches , 1990 .
[13] J. Eyles,et al. Oral and nasal immunization with microencapsulated clinically relevant proteins , 1998 .
[14] A. Fasano,et al. Innovative strategies for the oral delivery of drugs and peptides. , 1998, Trends in biotechnology.
[15] M. Alonso,et al. Design of microencapsulated chitosan microspheres for colonic drug delivery. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[16] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[17] W. Shalaby. Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies. , 1995, Clinical immunology and immunopathology.
[18] J. Kreuter,et al. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs , 1996 .
[19] J. Kreuter. Nanoparticles and microparticles for drug and vaccine delivery. , 1996, Journal of anatomy.